Introduction:

The microsatellite instability (MSI) pathway is involved in the carcinogenesis of 15% of colorectal carcinomas (CRC). The detection of this alteration is relevant for the prognosis and treatment of CRC patients.

Objective:

The aim of this study is to determine the prevalence of MSI in CRC in a cohort of patients in Bogotá, Colombia.

Materials and methods:

The presence of MLH1, PMS2, MSH2, and MSH6 was evaluated by immunohistochemistry in CRC samples collected during colectomy. Clinicopathological variables were analyzed as well. Cases with loss of MLH1 and PMS2 were evaluated for BRAF gene mutation.

Results:

A total of 86 cases were included. The median age was 69 years, 52.3% were male. 12 (13.9%) patients had IMS, 10 (83.3%) had absence of MLH1/PMS2 expression and 2 (16.7%) absence of MSH2/MSH6 expression. The median age of patients with IMS was 52 years (45-76.5), of which 9 were male. 66.7% of carcinomas were located in the right colon and the most frequent histological type was moderately differentiated adenocarcinoma (67%). Tumor infiltrating lymphocytes were observed in 83% of the cases, while the presence of Crohn’s-like infiltrate was present in 42%. BRAF mutation was observed in 30% of patients with loss of MLH1 and PMS2.

Conclusion:

The prevalence of IMS in our population was 14%, similar to the data observed in the North American and European populations. However, we observed that 83% had loss of expression of the MLH1/PMS2 complex, a higher prevalence compared to other populations.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )